Implantable Cardioverter Defibrillators (ICD)

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 201...

August 11, 2014 — Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators (CRT-...

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary prev...

ICD Implants Heart Rhythm Society Clinical Study Insurance Male

A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable cardioverter defibrillator (ICD) procedures. ...

Medtronic, Attain Performa, quadripolar leads
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV)...
implantable cardioverter defibrillator, ep lab, leads, implantable devices
A new study evaluating Optim-insulated implantable cardioverter defibrillator (ICD) leads found low rates of all-cause mechanical failure during a median...
Most patients with implantable cardioverter defibrillators (ICDs) haven’t thought about device deactivation if they were to develop a serious illness from...
Boston Scientific Corp. announced that its subcutaneous implantable defibrillator (S-ICD System) will have designated Current Procedural Terminology (CPT...
Ecolab Healthcare's PD220 patient drape is the first to market specifically for Boston Scientific’s subcutaneous implantable cardioverter-
The CorMatrix Cardiovascular CorMatrix CanGaroo ECM Envelope is for use with cardiac implantable electronic devices (CIED’s) including...
Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable...
Medtronic received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad...

Articles

Medtronic, Attain Performa, quadripolar leads
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV)...
September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease...
May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-...
ICD Implants Heart Rhythm Society Clinical Study Insurance Male
A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance...

Video Center

There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
2 days 23 hours ago
All major technology advances in the world of radiology, including cardiac imaging, are unveiled or...
3 weeks 6 days ago
By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
12 weeks 2 days ago
The CME webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" will educate participants in the state of the art clinical and emerging...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...